A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum.
The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo.
Pain in the pelvic region of genital and non-genital origin and of organic or psychogenic etiology. Frequent causes of pain are distension or contraction of hollow viscera, rapid stretching of the capsule of a solid organ, chemical irritation, tissue ischemia, and neuritis secondary to inflammatory, neoplastic, or fibrotic processes in adjacent organs. (Kase, Weingold & Gershenson: Principles and Practice of Clinical Gynecology, 2d ed, pp479-508)
Pathological processes involving the PERITONEUM.
Pathological processes of the OVARY.
Painful menstruation.
Diminished or absent ability of a female to achieve conception.
The serous fluid of ASCITES, the accumulation of fluids in the PERITONEAL CAVITY.
Pathological processes involving any part of the UTERUS.
A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders.
Pathological developments in the RECTUM region of the large intestine (INTESTINE, LARGE).
A procedure in which a laparoscope (LAPAROSCOPES) is inserted through a small incision near the navel to examine the abdominal and pelvic organs in the PERITONEAL CAVITY. If appropriate, biopsy or surgery can be performed during laparoscopy.
Recurrent genital pain occurring during, before, or after SEXUAL INTERCOURSE in either the male or the female.
The period from onset of one menstrual bleeding (MENSTRUATION) to the next in an ovulating woman or female primate. The menstrual cycle is regulated by endocrine interactions of the HYPOTHALAMUS; the PITUITARY GLAND; the ovaries; and the genital tract. The menstrual cycle is divided by OVULATION into two phases. Based on the endocrine status of the OVARY, there is a FOLLICULAR PHASE and a LUTEAL PHASE. Based on the response in the ENDOMETRIUM, the menstrual cycle is divided into a proliferative and a secretory phase.
Pathological processes involving the URETERS.
Pathological processes in the SIGMOID COLON region of the large intestine (INTESTINE, LARGE).
A species of baboon in the family CERCOPITHECIDAE with a somewhat different social structure than PAPIO HAMADRYAS. They inhabit several areas in Africa south of the Sahara.
Pathological processes of the VAGINA.
Connective tissue cells of an organ found in the loose connective tissue. These are most often associated with the uterine mucosa and the ovary as well as the hematopoietic system and elsewhere.
General term for CYSTS and cystic diseases of the OVARY.
The space or compartment surrounded by the pelvic girdle (bony pelvis). It is subdivided into the greater pelvis and LESSER PELVIS. The pelvic girdle is formed by the PELVIC BONES and SACRUM.
The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.
Diseases in any part of the GASTROINTESTINAL TRACT or the accessory organs (LIVER; BILIARY TRACT; PANCREAS).
Pathological processes of the URINARY BLADDER.
Variations of menstruation which may be indicative of disease.
Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.
A mass of histologically normal tissue present in an abnormal location.
Carbohydrate antigen most commonly seen in tumors of the ovary and occasionally seen in breast, kidney, and gastrointestinal tract tumors and normal tissue. CA 125 is clearly tumor-associated but not tumor-specific.
A potent synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE that regulates the synthesis and release of pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE.
Surgery performed on the female genitalia.
A membrane of squamous EPITHELIAL CELLS, the mesothelial cells, covered by apical MICROVILLI that allow rapid absorption of fluid and particles in the PERITONEAL CAVITY. The peritoneum is divided into parietal and visceral components. The parietal peritoneum covers the inside of the ABDOMINAL WALL. The visceral peritoneum covers the intraperitoneal organs. The double-layered peritoneum forms the MESENTERY that suspends these organs from the abdominal wall.
Disorders affecting the organs of the thorax.
A sac or recess formed by a fold of the peritoneum.
The pit in the center of the ABDOMINAL WALL marking the point where the UMBILICAL CORD entered in the FETUS.
Methods and procedures for the diagnosis of conditions related to pregnancy, labor, and the puerperium and of diseases of the female genitalia. It includes also demonstration of genital and pregnancy physiology.
Inability to reproduce after a specified period of unprotected intercourse. Reproductive sterility is permanent infertility.
The outer margins of the ABDOMEN, extending from the osteocartilaginous thoracic cage to the PELVIS. Though its major part is muscular, the abdominal wall consists of at least seven layers: the SKIN, subcutaneous fat, deep FASCIA; ABDOMINAL MUSCLES, transversalis fascia, extraperitoneal fat, and the parietal PERITONEUM.
The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus (the body) which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.
A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, consisting of five named species: PAPIO URSINUS (chacma baboon), PAPIO CYNOCEPHALUS (yellow baboon), PAPIO PAPIO (western baboon), PAPIO ANUBIS (or olive baboon), and PAPIO HAMADRYAS (hamadryas baboon). Members of the Papio genus inhabit open woodland, savannahs, grassland, and rocky hill country. Some authors consider MANDRILLUS a subgenus of Papio.

Molecular and cellular aspects of endometrial receptivity. (1/1690)

Endocrine and paracrine controls regulate the endometrium during the luteal phase of the cycle to permit implantation. Part of this differentiation process is the production of a specific secretion which fills the intrauterine cavity and glandular lumen. Its molecular composition originates from the gland secretion, from transudations from stroma, from the endometrial blood vessels, and last, but not least, from cellular components of apoptotic and exfoliated cells. We have studied the secretions of all phases during the menstrual cycle using patterns evaluated by SDS-PAGE, by laser densitometry or Western blots. Uterine secretion electrophoresis (USE) permits detailed analyses of the intrauterine micromilieu and allows clinical assessment of the receptive stage of endometrium during the luteal phase. Several individual protein bands have been defined as characteristic markers for such receptive pattern. We have isolated and identified the molecular structure of several of these proteins, e.g. histones, cyclophilin, transthyretin, haptoglobin and uteroglobin. Investigations on the endocrine regulation of these proteins, were carried out on the uterine secretions of patients treated with progesterone antagonists (mifepristone and onapristone). The results demonstrate how progesterone-dependent components produce a receptive pattern, which can serve as a useful and precise marker in the clinical diagnosis of the luteal phase. Essential progesterone-dependent components differentiating during the luteal phase may provide new targets for contraceptive interventions by preventing the physiological changes typical of receptivity.  (+info)

Decreased apoptosis and sensitivity to macrophage mediated cytolysis of endometrial cells in endometriosis. (2/1690)

Ectopic dissemination of endometrial cells and their subsequent implantation are the mechanisms involved in the development of endometriosis. While the process of dissemination appears to be a phenomenon common to all women, it is unknown what facilitates or prevents ectopic implantation of misplaced endometrial cells. Prior studies by our group and others suggest that cell-mediated immunity in patients with endometriosis is decreased. The present studies evaluated (i) peripheral blood monocyte (PBM) and peritoneal macrophage (PM) mediated cytolysis of autologous eutopic and ectopic endometrial cells and (ii) programmed cell death (apoptosis) in the eutopic and ectopic endometrium. PBM-mediated cytolysis was (mean+/-SD) 23.1+/-13% for the eutopic and 7.8+/-% for the ectopic endometrium (P < 0.004), while the corresponding percentages for PM-mediated cytolysis were 5.4+/-7 and 0.3+/-1 respectively (P < 0.04). This indicates that PBM are much more effective than PM in inducing cytolysis of both eutopic and ectopic endometrium and that ectopic endometrial cells are significantly more resistant to both PBM- and PM-mediated cytolysis. The apoptosis was significantly decreased in the eutopic endometrium of women with endometriosis as compared to fertile controls (0.375+/-0.17 versus 1.57+/-0.3, P < 0.0001). Furthermore, in matched samples apoptosis was significantly lower in the ectopic (0.149+/-0.075) than eutopic (0.375+/-0.17) endometrium (P < 0.001). We conclude from these studies that the decrease in the capacity of monocytes to mediate cytolysis of the misplaced endometrial cells in the peritoneal locations and an increased resistance of these cells to apoptosis are fundamental to the aetiology and/or pathophysiology of endometriosis.  (+info)

Phenotypic and functional studies of leukocytes in human endometrium and endometriosis. (3/1690)

The aetiology of endometriosis, a common and disabling disorder, is presently unknown, although immune dysfunction could allow ectopic endometrial fragments to survive outside the uterine cavity. These studies investigate the relationship between leukocyte populations, steroid hormone receptor expression, proliferative activity, bcl-2 expression and apoptosis in eutopic and ectopic endometrium from women with endometriosis or adenomyosis at different phases of the menstrual cycle. Significantly increased oestrogen receptor expression, bcl-2 expression and numbers of CD8+ leukocytes were found in ectopic compared with eutopic endometrium in endometriosis, and CD56+ endometrial granulated lymphocytes (eGLs) were significantly reduced in ectopic endometrium. Apoptotic cells were rarely found in control and subject endometria. In contrast with endometriosis, adenomyotic lesions showed identical steroid hormone receptor expression, proliferative activity, bcl-2 expression and leukocyte subpopulations to eutopic endometrium, indicating different aetiologies for these disorders. The unusual CD56+ CD16- eGLs present in large numbers in late secretory phase eutopic endometrium were highly purified (>98%) by immunomagnetic separation. Except for a negligible cytotoxic activity of eGLs from early proliferative samples, cytotoxic activity of eGLs from non-pregnant endometrium during the menstrual cycle was comparable with those in peripheral blood, predominantly CD56+ CD16+ natural killer cells. eGLs from non-pregnant endometrium and early pregnancy showed a variable proliferative response to 5 and 100 U/ml interleukin-2 over 48-h and 120-h time courses. eGLs are evidently functionally important in the eutopic endometrium. Their absence in endometriotic lesions together with increased CD+8 T-cell numbers and increased oestrogen receptor and bcl-2 expression may have significant effects on the development and progression of endometriosis.  (+info)

Expression pattern of integrin adhesion molecules in endometriosis and human endometrium. (4/1690)

Integrins are cell adhesion molecules that undergo cell-specific dynamic changes during the normal menstrual cycle in the human endometrium. Here, using immunohistochemistry, we have investigated the expression pattern of the integrins alphav, alpha2beta1, alpha3beta1, alpha3, alpha6, beta1, beta2 and beta3 in the human ectopic endometrium of 30 patients and in nine cases in the corresponding eutopic endometrium. The biopsies were obtained during the early or late follicular phase (25 cases), during the corpus luteum phase (four cases) and in one case after 6 months' treatment with a gonadotrophin releasing hormone (GnRH) agonist. The integrin expression was independent of the ovarian steroid situation at the time of biopsy. The integrin alpha6 was expressed in all endometriotic and endometrium samples. The integrin alpha3 was absent in all endometrium tissues of patients with endometriosis. However, the corresponding endometriotic lesions re-expressed this adhesion molecule in 15 cases. No change in integrin beta3 expression pattern could be demonstrated in either endometriotic lesions or endometrium samples, regardless of the menstrual cycle phase. A correlation between serum oestradiol and progesterone concentrations and the expression of the investigated integrins was not observed, thus indicating that these two hormones play a minor role in the regulation of the cell adhesion molecules examined. Our investigation suggests that endometriosis is a dedifferentiated disease as it expressed different integrins in comparison with the eutopic endometrium, and independently of the hormonal situation. The ability of endometriotic tissues to express integrins may explain the high recurrence rates in patients with endometriosis, as these samples retain their adhesion potency after retrograde menstruation and are thus able to establish cell-cell and cell-matrix interactions with the surrounding peritoneum.  (+info)

Paracrine changes in the peritoneal environment of women with endometriosis. (5/1690)

During the past decade, macrophage-derived substances such as prostanoids, cytokines, growth factors and angiogenic factors have been detected in the peritoneal fluid of women with endometriosis. In particular, growth-promoting and angiogenic factors are considered to be substantially involved in the pathogenesis of endometriosis. In this study, vascular endothelial growth factor (VEGF), transforming growth factor beta (TGF-beta) and intercellular adhesion molecule 1 (ICAM-1), substances recently detected in the peritoneal fluid of women with endometriosis, were assessed with regard to their concentrations in different stages of endometriosis and changes of the peritoneal paracrine activity after medical treatment with a gonadotrophin releasing hormone agonist (GnRHa). Peritoneal fluid was obtained from patients with endometriosis during laparoscopy before and after a 4-month treatment with a GnRHa. VEGF, TGF-beta and ICAM-1 could be detected in all women presenting with various stages of active endometriosis. After GnRHa therapy, all patients showed significant decreases in mean concentrations of VEGF (194+/-77 pg/ml), TGF-beta (902+/-273 pg/ml) and ICAM-1 (157+/-52 ng/ml). Patients with stage III and IV endometriosis (according to the rAFS score) had much higher concentrations of VEGF and TGF-beta before treatment compared with those patients with mild endometriosis (rAFS stages I and II). The most striking decrease in concentration was for TGF-beta, from 902 pg/ml before to 273 pg/ml after therapy. These results indicate an important role for paracrine activity in the establishment and maintenance of endometriosis. Indeed, treatment with a GnRHa may reduce paracrine activity in the peritoneal cavity via hypo-oestrogenism and provide proof of successful therapy.  (+info)

Tracing cellular and molecular mechanisms involved in endometriosis. (6/1690)

The aetiology and pathogenesis of endometriosis, defined as the presence of endometrium-like tissue outside the uterine cavity, is largely unknown. In this paper we present and discuss possibilities to study the putative pathogenic properties of endometriotic cells in vitro. The current focus of our investigations is on the invasive phenotype of the disease, assuming that this might contribute to the pathogenesis of endometriosis. So far, we have shown that: (i) cytokeratin-positive and E-cadherin-negative endometriotic cells have an invasive phenotype in a collagen invasion assay in vitro similar to metastatic carcinoma cells; (ii) the invasiveness of endometriotic but not of eutopic endometrial cells can be stimulated by a heat-stable protein present in peritoneal fluid; and (iii) the endometriotic cell line EEC145T, which we established, may be a useful tool for the identification of gene products which are, positively or negatively, invasion-related. Finally, our studies suggest that the invasive phenotype in endometriosis shares aspects with tumour metastasis, but might also have unique mechanisms.  (+info)

Extracellular matrix remodelling in the endometrium and its possible relevance to the pathogenesis of endometriosis. (7/1690)

Essential features of endometrial physiology involve the extracellular matrix (ECM). In the pathogenesis of endometriosis, interactions of endometriosis cells with ECM can be postulated. Two systems of secreted proteases in the endometrium, the plasmin(ogen) activator/inhibitor and the matrix metalloproteinases and their inhibitors were examined in cell cultures of uterine endometrial cells from women with and without endometriosis. Soluble urokinase receptor secretion is increased, and mRNA transcription of tissue inhibitor of metalloproteinases-2 (TIMP-2) is upregulated by progestin in endometriosis. These findings are compatible with an altered ECM turnover in the endometrium of these patients that may explain a higher invasive potential of retrogradely menstruated endometrial fragments.  (+info)

Angiogenesis: a new theory for endometriosis. (8/1690)

Excessive endometrial angiogenesis is proposed as an important mechanism in the pathogenesis of endometriosis. Evidence is reviewed for the hypothesis that the endometrium of women with endometriosis has an increased capacity to proliferate, implant and grow in the peritoneal cavity. Data is summarized indicating that the endometrium of patients with endometriosis shows enhanced endothelial cell proliferation. Results are also reviewed indicating that the cell adhesion molecule integrin alphavbeta3 is expressed in more blood vessels in the endometrium of women with endometriosis when compared with normal women. Taken together, these results provide evidence for increased endometrial angiogenesis in women with endometriosis when compared with normal subjects. Endometriosis is one of the family of angiogenic diseases. Other angiogenic diseases include solid tumours, rheumatoid arthritis, psoriasis and diabetic retanopathy. Excessive endometrial angiogenesis suggests novel new medical treatments for endometriosis aimed at the inhibition of angiogenesis.  (+info)

Endometriosis is a medical condition in which tissue similar to the lining of the uterus (endometrium) grows outside the uterine cavity, most commonly on the ovaries, fallopian tubes, and the pelvic peritoneum. This misplaced endometrial tissue continues to act as it would inside the uterus, thickening, breaking down, and bleeding with each menstrual cycle. However, because it is outside the uterus, this blood and tissue have no way to exit the body and can lead to inflammation, scarring, and the formation of adhesions (tissue bands that bind organs together).

The symptoms of endometriosis may include pelvic pain, heavy menstrual periods, painful intercourse, and infertility. The exact cause of endometriosis is not known, but several theories have been proposed, including retrograde menstruation (the backflow of menstrual blood through the fallopian tubes into the pelvic cavity), genetic factors, and immune system dysfunction.

Endometriosis can be diagnosed through a combination of methods, such as medical history, physical examination, imaging tests like ultrasound or MRI, and laparoscopic surgery with tissue biopsy. Treatment options for endometriosis include pain management, hormonal therapies, and surgical intervention to remove the misplaced endometrial tissue. In severe cases, a hysterectomy (removal of the uterus) may be recommended, but this is typically considered a last resort due to its impact on fertility and quality of life.

The endometrium is the innermost layer of the uterus, which lines the uterine cavity and has a critical role in the menstrual cycle and pregnancy. It is composed of glands and blood vessels that undergo cyclic changes under the influence of hormones, primarily estrogen and progesterone. During the menstrual cycle, the endometrium thickens in preparation for a potential pregnancy. If fertilization does not occur, it will break down and be shed, resulting in menstruation. In contrast, if implantation takes place, the endometrium provides essential nutrients to support the developing embryo and placenta throughout pregnancy.

Pelvic pain is defined as discomfort or unpleasant sensation in the lower abdominal region, below the belly button, and between the hips. It can be acute (sudden and lasting for a short time) or chronic (persisting for months or even years), and it may be steady or intermittent, mild or severe. The pain can have various causes, including musculoskeletal issues, nerve irritation, infection, inflammation, or organic diseases in the reproductive, urinary, or gastrointestinal systems. Accurate diagnosis often requires a thorough medical evaluation to determine the underlying cause and develop an appropriate treatment plan.

Peritoneal diseases refer to a group of conditions that affect the peritoneum, which is the thin, transparent membrane that lines the inner wall of the abdomen and covers the organs within it. The peritoneum has several functions, including providing protection and support to the abdominal organs, producing and absorbing fluids, and serving as a site for the immune system's response to infections and other foreign substances.

Peritoneal diseases can be broadly classified into two categories: infectious and non-infectious. Infectious peritoneal diseases are caused by bacterial, viral, fungal, or parasitic infections that spread to the peritoneum from other parts of the body or through contaminated food, water, or medical devices. Non-infectious peritoneal diseases, on the other hand, are not caused by infections but rather by other factors such as autoimmune disorders, cancer, or chemical irritants.

Some examples of peritoneal diseases include:

1. Peritonitis: Inflammation of the peritoneum due to bacterial or fungal infections, often caused by a ruptured appendix, perforated ulcer, or other abdominal injuries or conditions.
2. Tuberculous peritonitis: A form of peritonitis caused by Mycobacterium tuberculosis, the bacterium that causes tuberculosis (TB).
3. Peritoneal dialysis-associated peritonitis: Infection of the peritoneum in patients undergoing peritoneal dialysis, a type of kidney replacement therapy for patients with end-stage renal disease.
4. Malignant peritoneal mesothelioma: A rare and aggressive form of cancer that affects the mesothelial cells lining the peritoneum, often caused by exposure to asbestos.
5. Systemic lupus erythematosus (SLE): An autoimmune disorder that can cause inflammation and scarring of the peritoneum.
6. Peritoneal carcinomatosis: The spread of cancer cells from other parts of the body to the peritoneum, often seen in patients with advanced ovarian or colorectal cancer.
7. Cirrhotic ascites: Fluid accumulation in the peritoneal cavity due to liver cirrhosis and portal hypertension.
8. Meigs' syndrome: A rare condition characterized by the presence of a benign ovarian tumor, ascites, and pleural effusion.

Ovarian diseases refer to a range of conditions that affect the function and health of the ovaries, which are the female reproductive organs responsible for producing eggs (oocytes) and female hormones estrogen and progesterone. These diseases can be categorized into functional disorders, infectious and inflammatory diseases, neoplastic diseases, and other conditions that impact ovarian function. Here's a brief overview of some common ovarian diseases:

1. Functional Disorders: These are conditions where the ovaries experience hormonal imbalances or abnormal functioning, leading to issues such as:
* Polycystic Ovary Syndrome (PCOS): A condition characterized by hormonal imbalances that can cause irregular periods, cysts in the ovaries, and symptoms like acne, weight gain, and infertility.
* Functional Cysts: Fluid-filled sacs that develop within the ovary, usually as a result of normal ovulation (follicular or corpus luteum cysts). They're typically harmless and resolve on their own within a few weeks or months.
2. Infectious and Inflammatory Diseases: These conditions are caused by infections or inflammation affecting the ovaries, such as:
* Pelvic Inflammatory Disease (PID): An infection that spreads to the reproductive organs, including the ovaries, fallopian tubes, and uterus. It's often caused by sexually transmitted bacteria like Chlamydia trachomatis or Neisseria gonorrhoeae.
* Tuberculosis (TB): A bacterial infection that can spread to the ovaries and cause inflammation, abscesses, or scarring.
3. Neoplastic Diseases: These are conditions where abnormal growths or tumors develop in the ovaries, which can be benign (non-cancerous) or malignant (cancerous). Examples include:
* Ovarian Cysts: While some cysts are functional and harmless, others can be neoplastic. Benign tumors like fibromas, dermoids, or cystadenomas can grow significantly larger and cause symptoms like pain or bloating. Malignant tumors include epithelial ovarian cancer, germ cell tumors, and sex cord-stromal tumors.
4. Other Conditions: Various other conditions can affect the ovaries, such as:
* Polycystic Ovary Syndrome (PCOS): A hormonal disorder that causes enlarged ovaries with small cysts. It's associated with irregular periods, infertility, and increased risk of diabetes, high blood pressure, and heart disease.
* Premature Ovarian Failure (POF): Also known as primary ovarian insufficiency, it occurs when the ovaries stop functioning before age 40, leading to menstrual irregularities, infertility, and early onset of menopause.

It's essential to consult a healthcare professional if you experience any symptoms related to your reproductive system or suspect an issue with your ovaries. Early detection and treatment can significantly improve the prognosis for many conditions affecting the ovaries.

Dysmenorrhea is a medical term that refers to painful menstrual cramps and discomfort during menstruation. It's one of the most common gynecological complaints among women of reproductive age. There are two types of dysmenorrhea: primary and secondary.

1. Primary Dysmenorrhea: This type is more common and occurs in women who have had normal, pelvic anatomy. The pain is caused by strong contractions of the uterus due to the production of prostaglandins (hormone-like substances that are involved in inflammation and pain). Primary dysmenorrhea usually starts soon after menarche (the beginning of menstruation) and tends to improve with age, particularly after childbirth.
2. Secondary Dysmenorrhea: This type is less common and occurs due to an underlying medical condition affecting the reproductive organs, such as endometriosis, uterine fibroids, pelvic inflammatory disease (PID), or adenomyosis. The pain associated with secondary dysmenorrhea tends to worsen over time and may be accompanied by other symptoms like irregular menstrual bleeding, pain during intercourse, or chronic pelvic pain.

Treatment for dysmenorrhea depends on the type and underlying cause. For primary dysmenorrhea, nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen can help alleviate pain by reducing prostaglandin production. Hormonal birth control methods like oral contraceptives and intrauterine devices (IUDs) may also be prescribed to reduce menstrual pain. For secondary dysmenorrhea, treatment typically involves addressing the underlying medical condition causing the pain.

Female infertility is a condition characterized by the inability to conceive after 12 months or more of regular, unprotected sexual intercourse or the inability to carry a pregnancy to a live birth. The causes of female infertility can be multifactorial and may include issues with ovulation, damage to the fallopian tubes or uterus, endometriosis, hormonal imbalances, age-related factors, and other medical conditions.

Some common causes of female infertility include:

1. Ovulation disorders: Conditions such as polycystic ovary syndrome (PCOS), thyroid disorders, premature ovarian failure, and hyperprolactinemia can affect ovulation and lead to infertility.
2. Damage to the fallopian tubes: Pelvic inflammatory disease, endometriosis, or previous surgeries can cause scarring and blockages in the fallopian tubes, preventing the egg and sperm from meeting.
3. Uterine abnormalities: Structural issues with the uterus, such as fibroids, polyps, or congenital defects, can interfere with implantation and pregnancy.
4. Age-related factors: As women age, their fertility declines due to a decrease in the number and quality of eggs.
5. Other medical conditions: Certain medical conditions, such as diabetes, celiac disease, and autoimmune disorders, can contribute to infertility.

In some cases, female infertility can be treated with medications, surgery, or assisted reproductive technologies (ART) like in vitro fertilization (IVF). A thorough evaluation by a healthcare professional is necessary to determine the underlying cause and develop an appropriate treatment plan.

Ascitic fluid is defined as the abnormal accumulation of fluid in the peritoneal cavity, which is the space between the two layers of the peritoneum, a serous membrane that lines the abdominal cavity and covers the abdominal organs. This buildup of fluid, also known as ascites, can be caused by various medical conditions such as liver cirrhosis, cancer, heart failure, or infection. The fluid itself is typically straw-colored and clear, but it may also contain cells, proteins, and other substances depending on the underlying cause. Analysis of ascitic fluid can help doctors diagnose and manage the underlying condition causing the accumulation of fluid.

Uterine diseases refer to a range of medical conditions that affect the uterus, which is the reproductive organ in females where fetal development occurs. These diseases can be categorized into structural abnormalities, infectious diseases, and functional disorders. Here are some examples:

1. Structural abnormalities: These include congenital malformations such as septate uterus or bicornuate uterus, as well as acquired conditions like endometrial polyps, fibroids (benign tumors of the muscular wall), and adenomyosis (where the endometrial tissue grows into the muscular wall).

2. Infectious diseases: The uterus can be affected by various infections, including bacterial, viral, fungal, or parasitic agents. Examples include pelvic inflammatory disease (PID), tuberculosis, and candidiasis.

3. Functional disorders: These are conditions that affect the normal functioning of the uterus without any apparent structural abnormalities or infections. Examples include dysmenorrhea (painful periods), menorrhagia (heavy periods), and endometriosis (where the endometrial tissue grows outside the uterus).

4. Malignant diseases: Uterine cancer, including endometrial cancer and cervical cancer, are significant health concerns for women.

5. Other conditions: Miscarriage, ectopic pregnancy, and infertility can also be considered as uterine diseases since they involve the abnormal functioning or structural issues of the uterus.

Danazol is a synthetic, orally active androgenic steroid with antigonadotropic properties. It is used primarily in the treatment of endometriosis, fibrocystic breast disease, and hereditary angioedema. Danazol works by suppressing the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland, which in turn inhibits the growth of ovarian tissue and reduces the production of estrogen and progesterone. This leads to a decrease in the symptoms associated with endometriosis and fibrocystic breast disease. In the case of hereditary angioedema, danazol helps prevent attacks by increasing the levels of a protein called C1 esterase inhibitor, which is necessary for regulating the immune system and preventing inflammation.

The common side effects of danazol include weight gain, acne, oily skin, increased hair growth, changes in menstrual cycle, decreased breast size, deepening of the voice, and emotional lability. Rare but serious side effects may include liver damage, blood clots, and adrenal gland problems. Danazol is contraindicated in pregnancy due to its potential virilizing effects on the fetus. It should be used with caution in individuals with a history of liver disease, heart disease, or seizure disorders.

The medical definition of danazol can be summarized as follows:

Danazol (dan-a-zole)

A synthetic androgenic steroid with antigonadotropic properties, used primarily in the treatment of endometriosis, fibrocystic breast disease, and hereditary angioedema. Danazol suppresses the release of FSH and LH from the pituitary gland, inhibiting ovarian tissue growth and reducing estrogen and progesterone production. In hereditary angioedema, danazol increases C1 esterase inhibitor levels to prevent attacks. Common side effects include weight gain, acne, increased hair growth, menstrual changes, decreased breast size, deepened voice, and emotional lability. Rare but serious side effects may involve liver damage, blood clots, or adrenal gland problems. Danazol is contraindicated in pregnancy due to potential virilizing effects on the fetus and should be used with caution in individuals with a history of liver disease, heart disease, or seizure disorders.

Rectal diseases refer to conditions that affect the structure or function of the rectum, which is the lower end of the large intestine, just above the anus. The rectum serves as a storage area for stool before it is eliminated from the body. Some common rectal diseases include:

1. Hemorrhoids: Swollen veins in the rectum or anus that can cause pain, itching, bleeding, and discomfort.
2. Rectal cancer: Abnormal growth of cells in the rectum that can invade and destroy nearby tissue and spread to other parts of the body.
3. Anal fissures: Small tears in the lining of the anus that can cause pain, bleeding, and itching.
4. Rectal prolapse: A condition where the rectum slips outside the anus, causing discomfort, fecal incontinence, and other symptoms.
5. Inflammatory bowel disease (IBD): A group of chronic inflammatory conditions that affect the digestive tract, including the rectum, such as Crohn's disease and ulcerative colitis.
6. Rectal abscess: A collection of pus in the rectum caused by an infection, which can cause pain, swelling, and fever.
7. Fistula-in-ano: An abnormal connection between the rectum and the skin around the anus, which can cause drainage of pus or stool.
8. Rectal foreign bodies: Objects that are accidentally or intentionally inserted into the rectum and can cause injury, infection, or obstruction.

These are just a few examples of rectal diseases, and there are many other conditions that can affect the rectum. If you experience any symptoms related to the rectum, it is important to seek medical attention from a healthcare professional for proper diagnosis and treatment.

Laparoscopy is a surgical procedure that involves the insertion of a laparoscope, which is a thin tube with a light and camera attached to it, through small incisions in the abdomen. This allows the surgeon to view the internal organs without making large incisions. It's commonly used to diagnose and treat various conditions such as endometriosis, ovarian cysts, infertility, and appendicitis. The advantages of laparoscopy over traditional open surgery include smaller incisions, less pain, shorter hospital stays, and quicker recovery times.

Dyspareunia is a medical term that describes painful sexual intercourse. This condition can affect both men and women, but it is more commonly reported by women. The pain can occur in various locations, such as the vaginal opening, deep inside the vagina, or in the pelvic region. It can be caused by a variety of factors, including physical conditions like vulvodynia, endometriosis, or vaginal infections, as well as psychological factors like anxiety, depression, or relationship issues. Treatment for dyspareunia depends on the underlying cause and may include medication, therapy, or lifestyle changes.

The menstrual cycle is a series of natural changes that occur in the female reproductive system over an approximate 28-day interval, marking the body's preparation for potential pregnancy. It involves the interplay of hormones that regulate the growth and disintegration of the uterine lining (endometrium) and the release of an egg (ovulation) from the ovaries.

The menstrual cycle can be divided into three main phases:

1. Menstrual phase: The cycle begins with the onset of menstruation, where the thickened uterine lining is shed through the vagina, lasting typically for 3-7 days. This shedding occurs due to a decrease in estrogen and progesterone levels, which are hormones essential for maintaining the endometrium during the previous cycle.

2. Follicular phase: After menstruation, the follicular phase commences with the pituitary gland releasing follicle-stimulating hormone (FSH). FSH stimulates the growth of several ovarian follicles, each containing an immature egg. One dominant follicle usually becomes selected to mature and release an egg during ovulation. Estrogen levels rise as the dominant follicle grows, causing the endometrium to thicken in preparation for a potential pregnancy.

3. Luteal phase: Following ovulation, the ruptured follicle transforms into the corpus luteum, which produces progesterone and estrogen to further support the endometrial thickening. If fertilization does not occur within approximately 24 hours after ovulation, the corpus luteum will degenerate, leading to a decline in hormone levels. This drop triggers the onset of menstruation, initiating a new menstrual cycle.

Understanding the menstrual cycle is crucial for monitoring reproductive health and planning or preventing pregnancies. Variations in cycle length and symptoms are common among women, but persistent irregularities may indicate underlying medical conditions requiring further evaluation by a healthcare professional.

Ureteral diseases refer to a range of conditions that affect the ureters, which are the thin tubes that carry urine from the kidneys to the bladder. These diseases can cause various symptoms such as pain in the side or back, fever, and changes in urinary patterns. Here are some examples of ureteral diseases:

1. Ureteral stricture: A narrowing of the ureter that can be caused by scarring, inflammation, or tumors. This can lead to a backup of urine, which can cause kidney damage or infection.
2. Ureteral stones: Small, hard mineral deposits that form in the ureters and can cause pain, nausea, and blood in the urine.
3. Ureteral cancer: A rare type of cancer that affects the ureters and can cause symptoms such as abdominal pain, weight loss, and bloody urine.
4. Ureteral reflux: A condition in which urine flows backward from the bladder into the ureters, causing infection and kidney damage.
5. Ureteral trauma: Injury to the ureters can occur due to accidents, surgeries, or other medical procedures. This can lead to bleeding, scarring, or blockages in the ureters.

Treatment for ureteral diseases depends on the specific condition and its severity. Treatment options may include medications, surgery, or minimally invasive procedures such as stenting or balloon dilation.

"Sigmoid diseases" is not a widely recognized medical term. However, the sigmoid colon is a part of the large intestine, and it can be affected by various conditions such as:

1. Sigmoid diverticulitis: Inflammation or infection of small pouches (diverticula) that form on the wall of the sigmoid colon.
2. Sigmoid volvulus: Twisting of the sigmoid colon on itself, which can lead to obstruction and ischemia.
3. Sigmoid cancer: Malignant tumor arising from the epithelial cells lining the sigmoid colon.
4. Inflammatory bowel disease (IBD): Chronic inflammation of the intestine, including the sigmoid colon, that can lead to symptoms such as diarrhea, abdominal pain, and weight loss.
5. Irritable bowel syndrome (IBS): Functional gastrointestinal disorder characterized by abdominal pain, bloating, and altered bowel habits, which can affect the sigmoid colon.

Therefore, "sigmoid diseases" could refer to any of these conditions or others that specifically affect the sigmoid colon.

"Papio anubis" is the scientific name for the Olive Baboon, which is a species of Old World monkey found in savannas, open woodlands, and hills in East Africa. The term "Papio" refers to the genus of baboons, while "anubis" is the specific name for this particular species.

The Olive Baboon is named for its distinctive olive-gray fur, which can vary in color depending on the subspecies. They have a distinct dog-like face with a pink or red area around their mouths and noses. Adult males typically have a large, rough cheek pad on either side of their faces, which they use to display dominance during social interactions.

Olive Baboons are highly social animals that live in large troops consisting of several adult males, females, and their offspring. They have a complex social hierarchy based on age, size, and rank, and engage in various behaviors such as grooming, playing, and communication to maintain social bonds.

While "Papio anubis" is a medical or scientific term, it is not typically used in clinical settings. However, understanding the behavior and ecology of primates like Olive Baboons can provide valuable insights into human evolution, behavior, and disease transmission.

Vaginal diseases refer to various medical conditions that affect the vagina, which is the female reproductive organ that extends from the cervix (the lower part of the uterus) to the external part of the genitalia (vulva). These diseases can cause a range of symptoms, including discharge, itching, burning, pain, and discomfort. Some common vaginal diseases include:

1. Vaginitis: It is an inflammation or infection of the vagina that can cause abnormal discharge, itching, and irritation. The most common causes of vaginitis are bacterial vaginosis, yeast infections, and trichomoniasis.
2. Vulvovaginitis: It is an inflammation or infection of both the vagina and vulva that can cause redness, swelling, itching, and pain. The causes of vulvovaginitis are similar to those of vaginitis and include bacterial infections, yeast infections, and sexually transmitted infections (STIs).
3. Vaginal dryness: It is a common condition that affects many women, especially after menopause. It can cause discomfort during sexual intercourse and lead to other symptoms such as itching and burning.
4. Vaginal cysts: These are fluid-filled sacs that develop in the vagina due to various reasons, including inflammation, injury, or congenital abnormalities.
5. Vaginal cancer: It is a rare type of cancer that affects the vagina. The most common symptoms include abnormal vaginal bleeding, discharge, and pain during sexual intercourse.
6. Sexually transmitted infections (STIs): Several STIs, such as chlamydia, gonorrhea, genital herpes, and human papillomavirus (HPV), can affect the vagina and cause various symptoms, including discharge, pain, and sores.

It is essential to seek medical attention if you experience any symptoms of vaginal diseases to receive proper diagnosis and treatment.

Stromal cells, also known as stromal/stroma cells, are a type of cell found in various tissues and organs throughout the body. They are often referred to as the "connective tissue" or "supporting framework" of an organ because they play a crucial role in maintaining the structure and function of the tissue. Stromal cells include fibroblasts, adipocytes (fat cells), and various types of progenitor/stem cells. They produce and maintain the extracellular matrix, which is the non-cellular component of tissues that provides structural support and biochemical cues for other cells. Stromal cells also interact with immune cells and participate in the regulation of the immune response. In some contexts, "stromal cells" can also refer to cells found in the microenvironment of tumors, which can influence cancer growth and progression.

An ovarian cyst is a sac or pouch filled with fluid that forms on the ovary. Ovarian cysts are quite common in women during their childbearing years, and they often cause no symptoms. In most cases, ovarian cysts disappear without treatment over a few months. However, larger or persistent cysts may require medical intervention, including surgical removal.

There are various types of ovarian cysts, such as functional cysts (follicular and corpus luteum cysts), which develop during the menstrual cycle due to hormonal changes, and non-functional cysts (dermoid cysts, endometriomas, and cystadenomas), which can form due to different causes.

While many ovarian cysts are benign, some may have malignant potential or indicate an underlying medical condition like polycystic ovary syndrome (PCOS). Regular gynecological check-ups, including pelvic examinations and ultrasounds, can help detect and monitor ovarian cysts.

The pelvis is the lower part of the trunk, located between the abdomen and the lower limbs. It is formed by the fusion of several bones: the ilium, ischium, and pubis (which together form the hip bone on each side), and the sacrum and coccyx in the back. The pelvis has several functions including supporting the weight of the upper body when sitting, protecting the lower abdominal organs, and providing attachment for muscles that enable movement of the lower limbs. In addition, it serves as a bony canal through which the reproductive and digestive tracts pass. The pelvic cavity contains several vital organs such as the bladder, parts of the large intestine, and in females, the uterus, ovaries, and fallopian tubes.

Menstruation is the regular, cyclical shedding of the uterine lining (endometrium) in women and female individuals of reproductive age, accompanied by the discharge of blood and other materials from the vagina. It typically occurs every 21 to 35 days and lasts for approximately 2-7 days. This process is a part of the menstrual cycle, which is under the control of hormonal fluctuations involving follicle-stimulating hormone (FSH), luteinizing hormone (LH), estrogen, and progesterone.

The menstrual cycle can be divided into three main phases:

1. Menstruation phase: The beginning of the cycle is marked by the start of menstrual bleeding, which signals the breakdown and shedding of the endometrium due to the absence of pregnancy and low levels of estrogen and progesterone. This phase typically lasts for 2-7 days.

2. Proliferative phase: After menstruation, under the influence of rising estrogen levels, the endometrium starts to thicken and regenerate. The uterine lining becomes rich in blood vessels and glands, preparing for a potential pregnancy. This phase lasts from day 5 until around day 14 of an average 28-day cycle.

3. Secretory phase: Following ovulation (release of an egg from the ovaries), which usually occurs around day 14, increased levels of progesterone cause further thickening and maturation of the endometrium. The glands in the lining produce nutrients to support a fertilized egg. If pregnancy does not occur, both estrogen and progesterone levels will drop, leading to menstruation and the start of a new cycle.

Understanding menstruation is essential for monitoring reproductive health, identifying potential issues such as irregular periods or menstrual disorders, and planning family planning strategies.

The digestive system, also known as the gastrointestinal (GI) tract, is a series of organs that process food and liquids into nutrients and waste. Digestive system diseases refer to any conditions that affect the normal functioning of this system, leading to impaired digestion, absorption, or elimination of food and fluids.

Some common examples of digestive system diseases include:

1. Gastroesophageal Reflux Disease (GERD): A condition where stomach acid flows back into the esophagus, causing symptoms such as heartburn, chest pain, and difficulty swallowing.
2. Peptic Ulcer Disease: Sores or ulcers that develop in the lining of the stomach or duodenum, often caused by bacterial infection or long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs).
3. Inflammatory Bowel Disease (IBD): A group of chronic inflammatory conditions that affect the intestines, including Crohn's disease and ulcerative colitis.
4. Irritable Bowel Syndrome (IBS): A functional gastrointestinal disorder characterized by abdominal pain, bloating, and changes in bowel habits.
5. Celiac Disease: An autoimmune disorder where the ingestion of gluten leads to damage in the small intestine, impairing nutrient absorption.
6. Diverticular Disease: A condition that affects the colon, characterized by the formation of small pouches or sacs (diverticula) that can become inflamed or infected.
7. Constipation: A common digestive system issue where bowel movements occur less frequently than usual or are difficult to pass.
8. Diarrhea: Loose, watery stools that occur more frequently than normal, often accompanied by cramps and bloating.
9. Gallstones: Small, hard deposits that form in the gallbladder, causing pain, inflammation, and potential blockages of the bile ducts.
10. Hepatitis: Inflammation of the liver, often caused by viral infections or toxins, leading to symptoms such as jaundice, fatigue, and abdominal pain.

These are just a few examples of digestive system disorders that can affect overall health and quality of life. If you experience any persistent or severe digestive symptoms, it is important to seek medical attention from a healthcare professional.

Urinary bladder diseases refer to a range of conditions that affect the urinary bladder, a muscular sac located in the pelvis that stores urine before it is excreted from the body. These diseases can impair the bladder's ability to store or empty urine properly, leading to various symptoms and complications. Here are some common urinary bladder diseases with their medical definitions:

1. Cystitis: This is an inflammation of the bladder, often caused by bacterial infections (known as UTI - Urinary Tract Infection). However, it can also be triggered by irritants, radiation therapy, or chemical exposure.
2. Overactive Bladder (OAB): A group of symptoms that include urgency, frequency, and, in some cases, urge incontinence. The bladder muscle contracts excessively, causing a strong, sudden desire to urinate.
3. Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS): A chronic bladder condition characterized by pain, pressure, or discomfort in the bladder and pelvic region, often accompanied by urinary frequency and urgency. Unlike cystitis, IC/BPS is not caused by infection, but its exact cause remains unknown.
4. Bladder Cancer: The abnormal growth of cancerous cells within the bladder lining or muscle. It can present as non-muscle-invasive (superficial) or muscle-invasive, depending on whether the tumor has grown into the bladder muscle.
5. Bladder Diverticula: Small sac-like pouches that form in the bladder lining and protrude outward through its wall. These may result from increased bladder pressure due to conditions like OAB or an enlarged prostate.
6. Neurogenic Bladder: A condition where nerve damage or dysfunction affects the bladder's ability to store or empty urine properly. This can lead to symptoms such as incontinence, urgency, and retention.
7. Benign Prostatic Hyperplasia (BPH): Although not a bladder disease itself, BPH is a common condition in older men where the prostate gland enlarges, putting pressure on the bladder and urethra, leading to urinary symptoms like frequency, urgency, and hesitancy.

Understanding these various bladder conditions can help individuals identify potential issues early on and seek appropriate medical attention for proper diagnosis and treatment.

Menstruation disturbances, also known as menstrual disorders, refer to any irregularities or abnormalities in a woman's menstrual cycle. These disturbances can manifest in various ways, including:

1. Amenorrhea: The absence of menstrual periods for three consecutive cycles or more in women of reproductive age.
2. Oligomenorrhea: Infrequent or light menstrual periods that occur at intervals greater than 35 days.
3. Dysmenorrhea: Painful menstruation, often accompanied by cramping, pelvic pain, and other symptoms that can interfere with daily activities.
4. Menorrhagia: Heavy or prolonged menstrual periods that last longer than seven days or result in excessive blood loss, leading to anemia or other health complications.
5. Polymenorrhea: Abnormally frequent menstrual periods that occur at intervals of 21 days or less.
6. Metrorrhagia: Irregular and unpredictable vaginal bleeding between expected menstrual periods, which can be caused by various factors such as hormonal imbalances, infections, or structural abnormalities.

Menstruation disturbances can have significant impacts on a woman's quality of life, fertility, and overall health. They may result from various underlying conditions, including hormonal imbalances, polycystic ovary syndrome (PCOS), thyroid disorders, uterine fibroids, endometriosis, or sexually transmitted infections. Proper diagnosis and treatment of the underlying cause are essential for managing menstruation disturbances effectively.

A case-control study is an observational research design used to identify risk factors or causes of a disease or health outcome. In this type of study, individuals with the disease or condition (cases) are compared with similar individuals who do not have the disease or condition (controls). The exposure history or other characteristics of interest are then compared between the two groups to determine if there is an association between the exposure and the disease.

Case-control studies are often used when it is not feasible or ethical to conduct a randomized controlled trial, as they can provide valuable insights into potential causes of diseases or health outcomes in a relatively short period of time and at a lower cost than other study designs. However, because case-control studies rely on retrospective data collection, they are subject to biases such as recall bias and selection bias, which can affect the validity of the results. Therefore, it is important to carefully design and conduct case-control studies to minimize these potential sources of bias.

A choristoma is a type of growth that occurs when normally functioning tissue is found in an abnormal location within the body. It is not cancerous or harmful, but it can cause problems if it presses on surrounding structures or causes symptoms. Choristomas are typically congenital, meaning they are present at birth, and are thought to occur due to developmental errors during embryonic growth. They can be found in various organs and tissues throughout the body, including the brain, eye, skin, and gastrointestinal tract.

CA-125 antigen is a type of protein that is found on the surface of many ovarian cancer cells and is often used as a tumor marker to monitor the effectiveness of treatment and to detect recurrence of ovarian cancer. Elevated levels of CA-125 may also be present in other types of cancer, as well as nonmalignant conditions such as endometriosis, pelvic inflammatory disease, and cirrhosis. It is important to note that while CA-125 can be a useful tool in managing ovarian cancer, it is not specific to this type of cancer and should be used in conjunction with other diagnostic tests and clinical evaluations.

Leuprolide is a synthetic hormonal analog of gonadotropin-releasing hormone (GnRH or LHRH). It acts as a potent agonist of GnRH receptors, leading to the suppression of pituitary gland's secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). This, in turn, results in decreased levels of sex hormones such as testosterone and estrogen.

Leuprolide is used clinically for the treatment of various conditions related to hormonal imbalances, including:
- Prostate cancer: Leuprolide can help slow down the growth of prostate cancer cells by reducing testosterone levels in the body.
- Endometriosis: By lowering estrogen levels, leuprolide can alleviate symptoms associated with endometriosis such as pelvic pain and menstrual irregularities.
- Central precocious puberty: Leuprolide is used to delay the onset of puberty in children who experience it prematurely by inhibiting the release of gonadotropins.
- Uterine fibroids: Lowering estrogen levels with leuprolide can help shrink uterine fibroids and reduce symptoms like heavy menstrual bleeding and pelvic pain.

Leuprolide is available in various formulations, such as injectable depots or implants, for long-term hormonal suppression. Common side effects include hot flashes, mood changes, and potential loss of bone density due to prolonged hormone suppression.

Gynecologic surgical procedures refer to the operations that are performed on the female reproductive system and related organs. These surgeries can be either minimally invasive or open procedures, depending on the condition and the patient's health status.

The indications for gynecologic surgical procedures may include but are not limited to:

1. Diagnosis and treatment of various benign and malignant conditions such as uterine fibroids, ovarian cysts, endometriosis, and cancers of the reproductive organs.
2. Management of abnormal uterine bleeding, pelvic pain, and infertility.
3. Treatment of ectopic pregnancies and miscarriages.
4. Pelvic organ prolapse repair.
5. Sterilization procedures such as tubal ligation.
6. Investigation and treatment of suspicious lesions or abnormal Pap smears.

Some common gynecologic surgical procedures include hysterectomy (removal of the uterus), oophorectomy (removal of the ovary), salpingectomy (removal of the fallopian tube), cystectomy (removal of a cyst), myomectomy (removal of fibroids while preserving the uterus), and endometrial ablation (destruction of the lining of the uterus).

Minimally invasive surgical techniques such as laparoscopy and hysteroscopy have gained popularity in recent years due to their advantages over traditional open surgeries, including smaller incisions, less postoperative pain, quicker recovery times, and reduced risk of complications.

The peritoneum is the serous membrane that lines the abdominal cavity and covers the abdominal organs. It is composed of a mesothelial cell monolayer supported by a thin, loose connective tissue. The peritoneum has two layers: the parietal peritoneum, which lines the abdominal wall, and the visceral peritoneum, which covers the organs.

The potential space between these two layers is called the peritoneal cavity, which contains a small amount of serous fluid that allows for the smooth movement of the organs within the cavity. The peritoneum plays an important role in the absorption and secretion of fluids and electrolytes, as well as providing a surface for the circulation of immune cells.

In addition, it also provides a route for the spread of infection or malignant cells throughout the abdominal cavity, known as peritonitis. The peritoneum is highly vascularized and innervated, making it sensitive to pain and distention.

Thoracic diseases refer to a range of medical conditions that affect the thorax, which is the part of the body that includes the chest cage, lungs, pleura (lining of the lungs), mediastinum (the area between the lungs), and diaphragm. Examples of thoracic diseases include:

1. Chronic obstructive pulmonary disease (COPD): A progressive lung disease characterized by difficulty breathing, cough, and sputum production.
2. Asthma: A chronic inflammatory disorder of the airways that causes wheezing, shortness of breath, chest tightness, and coughing.
3. Lung cancer: A malignant tumor that forms in the tissues of the lungs, usually in the cells lining the air passages.
4. Pneumonia: An infection of the lung tissue that can be caused by bacteria, viruses, or fungi.
5. Tuberculosis (TB): A bacterial infection that mainly affects the lungs but can also affect other parts of the body.
6. Pleural effusion: An abnormal accumulation of fluid in the pleural space between the lungs and the chest wall.
7. Pneumothorax: A collection of air in the pleural space that causes the lung to collapse.
8. Lung fibrosis: A condition characterized by scarring and thickening of the lung tissue, leading to difficulty breathing.
9. Esophageal cancer: A malignant tumor that forms in the tissues of the esophagus, the tube that connects the throat to the stomach.
10. Thoracic aortic aneurysm: A bulging or weakened area in the wall of the thoracic aorta, the largest artery in the body.

These are just a few examples of thoracic diseases, and there are many others that can affect the chest and lungs.

The Douglas pouch, also known as the recto-uterine pouch or cul-de-sac of Douglas, is a potential space within the female pelvic cavity. It is located between the posterior wall of the uterus and the anterior wall of the rectum. This space can be examined during a gynecological examination, such as a transvaginal ultrasound or during surgery, to assess for any abnormalities or pathologies that may be present in this area.

The umbilicus, also known as the navel, is the scar left on the abdominal wall after the removal of the umbilical cord in a newborn. The umbilical cord connects the developing fetus to the placenta in the uterus during pregnancy, providing essential nutrients and oxygen while removing waste products. After birth, the cord is clamped and cut, leaving behind a small stump that eventually dries up and falls off, leaving the umbilicus. In adults, it typically appears as a slight depression or dimple on the abdomen.

Diagnostic techniques in obstetrics and gynecology refer to the various methods used by healthcare professionals to diagnose and monitor conditions related to the female reproductive system and pregnancy. Here are some commonly used diagnostic techniques:

1. Physical examination: A thorough physical exam, including a pelvic exam, can help identify any abnormalities in the reproductive organs.
2. Medical history: A detailed medical history, including information about menstrual cycles, sexual activity, and family health, can provide valuable clues to diagnose various conditions.
3. Imaging tests: Ultrasound, CT scans, and MRIs can help healthcare professionals visualize the reproductive organs and detect any abnormalities.
4. Laboratory tests: Blood tests, urine tests, and cultures can help identify infections, hormonal imbalances, and other conditions.
5. Biopsy: A small sample of tissue is taken from the affected area and examined under a microscope to diagnose conditions such as cancer.
6. Colposcopy: This procedure involves using a special magnifying device to examine the cervix and vagina for signs of abnormalities.
7. Hysterosalpingography: This is an X-ray procedure that involves injecting a dye into the uterus and fallopian tubes to detect any blockages or other abnormalities.
8. Sonohysterography: This is an ultrasound procedure that involves injecting a fluid into the uterus to help visualize its interior and detect any abnormalities.
9. Minimally invasive surgery: Procedures such as laparoscopy and hysteroscopy can help healthcare professionals diagnose and treat various conditions related to the reproductive organs.

These diagnostic techniques can help healthcare professionals identify and manage a wide range of conditions, including infertility, pregnancy complications, infections, hormonal imbalances, and cancer.

Infertility is a reproductive health disorder defined as the failure to achieve a clinical pregnancy after 12 months or more of regular, unprotected sexual intercourse or due to an impairment of a person's capacity to reproduce either as an individual or with their partner. It can be caused by various factors in both men and women, including hormonal imbalances, structural abnormalities, genetic issues, infections, age, lifestyle factors, and others. Infertility can have significant emotional and psychological impacts on individuals and couples experiencing it, and medical intervention may be necessary to help them conceive.

The abdominal wall refers to the group of muscles, fascia (sheaths of connective tissue), and skin that make up the front and sides of the abdomen, extending from the thorax (chest) to the pelvis. It provides protection to the abdominal organs, supports the trunk, and allows for movement of the torso.

The main muscles of the anterior abdominal wall include:

1. Rectus sheaths (Rectus Abdominis): paired vertical muscles running from the pubic symphysis to the xiphoid process and costal cartilages of ribs 5-7.
2. External obliques: thin, irregular muscles that lie over the lower part of the abdomen and run diagonally downward and forward from the lower ribs to the iliac crest (pelvic bone) and pubic tubercle.
3. Internal obliques: thicker muscles that lie under the external obliques, running diagonally upward and forward from the iliac crest to the lower ribs.
4. Transverse abdominis: deepest of the abdominal muscles, lying horizontally across the abdomen, attaching from the lower ribs to the pelvis.

These muscles are interconnected by various layers of fascia and aponeuroses (flat, broad tendons), forming a complex structure that allows for both stability and mobility. The linea alba, a fibrous band, runs down the midline of the anterior abdominal wall, connecting the rectus sheaths.

Damage to the abdominal wall can occur due to trauma, surgery, or various medical conditions, which may require surgical intervention for repair.

The uterus, also known as the womb, is a hollow, muscular organ located in the female pelvic cavity, between the bladder and the rectum. It has a thick, middle layer called the myometrium, which is composed of smooth muscle tissue, and an inner lining called the endometrium, which provides a nurturing environment for the fertilized egg to develop into a fetus during pregnancy.

The uterus is where the baby grows and develops until it is ready for birth through the cervix, which is the lower, narrow part of the uterus that opens into the vagina. The uterus plays a critical role in the menstrual cycle as well, by shedding its lining each month if pregnancy does not occur.

"Papio" is a term used in the field of primatology, specifically for a genus of Old World monkeys known as baboons. It's not typically used in human or medical contexts. Baboons are large monkeys with robust bodies and distinctive dog-like faces. They are native to various parts of Africa and are known for their complex social structures and behaviors.

No FAQ available that match "endometriosis"

No images available that match "endometriosis"